HIV drug-resistance patient registry study for people 14+
Part of Immune system & allergy, Infections clinical trials.
This study is a registry (a way to collect and organize information) for people living with HIV who have drug-resistant virus. It may help researchers better understand how resistant HIV behaves and how to manage treatment over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have HIV-1 infection
- You are older than 14 years
- Your HIV virus must show resistance in all 4 drug groups
- For each group (NRTI, NNRTI, PI, and INI), at least one drug must be resistant
- The resistance can be found from past testing or from testing done before joining
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining two or more investigational drugs that can activate the hidden HIV reservoir in your body might help eliminate it. The goal is to see if this approach is safe and could help lead to a cure for HIV.
This study looks at how well newer HIV medicines work in people starting treatment for the first time in Eastern Europe and Russia. It also checks for drug resistance to find better treatment strategies.
This study looks at how the immune system and HIV behave in people on long-term HIV treatment (ART), using blood samples that will be stored for future tests for up to 20 years. It may help researchers understand how well treatment is controlling HIV and improve future care.
This study looks at HIV drug resistance in people whose current HIV treatment is not keeping the virus under control. It helps doctors understand why some treatments stop working and how to choose better next steps.
This study looks at HIV in people who have just been diagnosed. It checks for drug resistance (whether the virus is resistant to certain medicines) and how the virus spreads, which can help doctors choose the best treatment for you and others.
This registry study looks at people who are HIV-negative but at high risk of getting HIV, to better understand risk and care needs. If you qualify, you may be asked to share health and behavior information to help guide future prevention efforts.
Hear when a new HIV-1-infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.